XML 39 R24.htm IDEA: XBRL DOCUMENT v3.22.2
Derivative Instruments and Activities
12 Months Ended
Apr. 30, 2022
Derivative Instruments and Activities [Abstract]  
Derivative Instruments and Activities
Note 15 – Derivative Instruments and Activities

From time to time, we enter into forward exchange and interest rate swap contracts as a hedge against foreign currency asset and liability commitments, changes in interest rates, and anticipated transaction exposures, including intercompany sales and purchases. All derivatives are recognized as assets or liabilities and measured at fair value. Derivatives that are not determined to be effective hedges are adjusted to fair value with a corresponding adjustment to earnings. We do not use financial instruments for trading or speculative purposes.

Interest Rate Contracts

As of April 30, 2022, we had total debt outstanding of $787.0 million, net of unamortized issuance costs of $0.3 million, of which $787.3 million are variable rate loans outstanding under the Amended and Restated RCA, which approximated fair value.

As of April 30, 2022 and 2021, the interest rate swap agreements we maintained were designated as fully effective cash flow hedges as defined under FASB ASC Topic 815, “Derivatives and Hedging” (ASC Topic 815). As a result, there was no impact on our Consolidated Statements of Income (Loss) from changes in the fair value of the interest rate swaps, as they were fully offset by changes in the interest expense on the underlying variable rate debt instruments. Under ASC Topic 815, derivative instruments that are designated as cash flow hedges have changes in their fair value recorded initially within Accumulated other comprehensive loss on the Consolidated Statements of Financial Position. As interest expense is recognized based on the variable rate loan agreements, the corresponding deferred gain or loss on the interest rate swaps is reclassified from Accumulated other comprehensive loss to Interest Expense on the Consolidated Statements of Income (Loss). It is management’s intention that the notional amount of interest rate swaps be less than the variable rate loans outstanding during the life of the derivatives.

The following table summarizes our interest rate swaps designated as cash flow hedges:

     
Notional Amount
          
       
As of April 30,
          
Hedged Item
Date entered into
Nature of Swap
 
2022
   
2021
   
Fixed Interest Rate
 
Variable Interest Rate
Amended and Restated RCA
April 7, 2022
Pay fixed/receive variable
 
$
100
   
$
     
2.646
%
1-month LIBOR reset every month for a 2-year period ending April 15, 2024
Amended and Restated RCA
April 12, 2021
Pay fixed/receive variable
   
100
     
100
     
0.500
%
1-month LIBOR reset every month for a 3-year period ending April 15, 2024
Amended and Restated RCA
February 26, 2020
Pay fixed/receive variable
   
100
     
100
     
1.150
%
1-month LIBOR reset every month for a 3-year period ending March 15, 2023
Amended and Restated RCA
August 7, 2019
Pay fixed/receive variable
   
100
     
100
     
1.400
%
1-month LIBOR reset every month for a 3-year period ending August 15, 2022
Amended and Restated RCA
June 24, 2019
Pay fixed/receive variable
   
100
     
100
     
1.650
%
1-month LIBOR reset every month for a 3-year period ending July 15, 2022
         
$
500
   
$
400
            

On April 4, 2016, we entered into a forward starting interest rate swap agreement which fixed a portion of the variable interest due on a variable rate debt renewal on May 16, 2016. Under the terms of the agreement, which expired on May 15, 2019, we paid a fixed rate of 0.920% and received a variable rate of interest based on one-month LIBOR from the counterparty which was reset every month for a three-year period ending May 15, 2019. Prior to expiration, the notional amount of the interest rate swap was $350.0 million.

We record the fair value of our interest rate swaps on a recurring basis using Level 2 inputs of quoted prices for similar assets or liabilities in active markets. The fair value of the interest rate swaps as of April 30, 2022 was a deferred loss of $0.2 million and a deferred gain of $5.8 million. Based on the maturity dates of the contracts, the entire deferred loss as of April 30, 2022 was recorded within Other accrued liabilities, $0.9 million of the deferred gain was recorded within Prepaid expenses and other current assets, and $4.9 million was recorded within Other non-current assets.

The fair value of the interest rate swaps as of April 30, 2021 was a deferred loss of $5.6 million. Based on the maturity dates of the contracts, the entire deferred loss as of April 30, 2021 was recorded within Other long-term liabilities.

The pretax (losses) gains that were reclassified from Accumulated other comprehensive loss into Interest expense for the years ended April 30, 2022, 2021, and 2020 were $(4.2) million, $(3.7) million, and $0.4 million, respectively. Based on the amount in Accumulated other comprehensive loss at April 30, 2022, approximately $1.6 million, net of tax, would be reclassified into Net income in the next twelve months.

Foreign Currency Contracts

We may enter into forward exchange contracts to manage our exposure on certain foreign currency denominated assets and liabilities. The forward exchange contracts are marked to market through Foreign exchange transaction (losses) gains on our Consolidated Statements of Income (Loss) and carried at fair value on our Consolidated Statements of Financial Position. Foreign currency denominated assets and liabilities are remeasured at spot rates in effect on the balance sheet date, with the affects of changes in spot rates reported in Foreign exchange transaction (losses) gains on our Consolidated Statements of Income (Loss).

As of April 30, 2022 and 2021, we did not maintain any open forward exchange contracts. In addition, we did not maintain any open forward contracts during the years ended April 30, 2022 and 2020.

During the year ended April 30, 2021, to manage foreign currency exposures on an intercompany loan, we entered into one forward exchange contract to sell €32 million and buy $38.8 million. This forward contract expired on April 15, 2021. We did not designate this forward exchange contract as a hedge under the applicable sections of ASC Topic 815 as the benefits of doing so were not material due to the short-term nature of the contract. The fair value changes in the forward exchange contract substantially mitigated the changes in the value of the applicable foreign currency denominated liability. The fair value of the open forward exchange contract was measured on a recurring basis using Level 2 inputs of quoted prices for similar assets or liabilities in active markets. For the year ended April 30, 2021, the loss recognized on this forward contract was $0.8 million and included in Foreign exchange transaction (losses) gains on our Consolidated Statement of Income (Loss).